InvestorsHub Logo
Followers 7
Posts 1173
Boards Moderated 0
Alias Born 11/13/2018

Re: flubber post# 211734

Thursday, 08/29/2019 11:16:07 AM

Thursday, August 29, 2019 11:16:07 AM

Post# of 425621
Every good drug has patent litigation. If the drug was crap you wouldn't see companies try and market a generic. It is part of the risk of biotech. This AMRN litigation has nothing to do with the AMGN litigation. AMGN litigation has to do with other marketed drugs. That is not the case with the current case. It is an overblown fear.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News